Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Corona Virus Clinical Trials

A listing of Corona Virus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (10) clinical trials

Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

Comparison of two groups of patients SARS-CoV-2 positive with severe acute respiratory syndrome Consecutively treated with low prolonged doses of methylprednisolone Historical patients never treated with corticosteroids The two group will be matched (1:1) according to the following criteria: sex age <10 years difference CRP level at admission (difference <20%) ...

Phase

COVID-19 Patients Characterization Biobank Treatment Response and Outcome Predictor

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Phase N/A

Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY

The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the incidence of cardiovascular complications in patients with COVID-19, and (2) ...

Phase N/A

Trial of Treatments for COVID-19 in Hospitalized Adults

This study is a multi-centre, adaptive, randomized, open clinical trial of the safety and efficacy of treatments of COVID-19 in hospitalized adults. The study is a multi-centre/country trial that will be conducted in various sites in Europe with Inserm as sponsor. Adults (18 year-old) hospitalized for COVID-19 with SpO2 94% ...

Phase

COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2

The proposed study is a prospective observational cohort design which will be carried out across three different trusts: Barts Health NHS Trust (St Bartholomew's Hospital, The Royal London Hospital, Whipps Cross Hospital and Newham Hospital), Royal Free London NHS Foundation Trust (Royal Free Hospital) and University College London Hospitals NHS ...

Phase N/A

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

The primary objective of this study is to determine whether short-term treatment with colchicine reduces the rate of death and lung complications related to COVID-19. The secondary objective is to determine the safety of treatment with colchicine in this patient population. Approximately 6000 patients will be enrolled to receive either ...

Phase

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing COVID19. The current strategy uses a public health model of identifying infected cases, isolation, and quarantine to stop transmission. Once exposed, observation is standard-of-care. Therapy to outpatients is generally not given. No effective therapy currently exists ...

Phase

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

To date, no targeted therapeutic treatments for the ongoing COVID-19 outbreak have been identified. Antiviral combined with adjuvant therapies are currently under investigation. The clinical spectrum of the infection is wide, ranging from mild signs of upper respiratory tract infection to severe pneumonia and death. In the patients who progress, ...

Phase

Escin in Patients With Covid-19 Infection

In December 2019,a new type of pneumonia caused by the coronavirus (COVID-2019) broke out in Wuhan ,China, and spreads quickly to other Chinese cities and 28 countries. More than 70000 people were infected and over 2000 people died all over the world. There is no specific drug treatment for this ...

Phase

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

In clinical institutions that enroll patients with corona virus disease 2019, three arms, multi-center, randomized and controlled methods are adopted. Patients are divided into three groups, favipiravir combined with tocilizumab group, favipiravir group and tocilizumab group. 150 patients are expected to be enrolled and the cases are allocated according to ...

Phase N/A